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Abstract 
Background: Implants are a predictable and well‑established treatment method in dentistry. Nevertheless, look‑
ing at possible failures of dental implants, early and late loss have to be distinguished. The intent of the study was to 
report microbiological findings on the surface of implants with severe peri‑implantitis, which had to be explanted.
Methods: 53 specimens of implants from 48 patients without severe general illnesses have been examined. The 
groups investigated were implants that had to be removed in the period of osseointegration (early loss, 13 patients 
with 14 implants) or after the healing period (late loss, 14 patients with 17 implants). The implant losses were com‑
pared with two control groups (implants with no bone loss directly after completed osseointegration, two to four 
months after implant placement (17 patients with 17 implants) and implants with no bone loss and prosthetic 
restoration for more than three years (5 patients with 5 implants)). Data about the bacteria located in the peri‑implant 
sulcus was collected using amplification and high throughput sequencing of the 16S rRNA gene.
Results: The biofilm composition differed substantially between individuals. Both in early and late implant loss, 
Fusobacterium nucleatum and Porphyromonas gingivalis were found to be abundant. Late lost implants showed higher 
bacterial diversity and in addition higher abundances of Treponema, Fretibacterium, Pseudoramibacter and Desulfobul-
bus, while microbial communities of early loss implants were very heterogeneous and showed no significantly more 
abundant bacterial taxa.
Conclusions: Specific peri‑implant pathogens were found around implants that were lost after a primarily unevent‑
ful osseointegration. P. gingivalis and F. nucleatum frequently colonized the implant in early and late losses and could 
therefore be characteristic for implant loss in general. In general, early lost implants showed also lower microbial 
diversity than late losses. However, the microbial results were not indicative of the causes of early and late losses.
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Background
The insertion of dental implants has become a routine 
and well predictable surgical procedure in the last dec-
ades, with high rates of osseointegration and long-term 
success [1]. Since the success of early implantology, 
this field has nowadays established itself in the daily 
treatment.
The reasons for tooth loss are multi-causal. Frequent 
problems are the development of caries at the mar-
gins of crowns, pulpal infections, periodontitis and 
mechanical complications, such as fractures of teeth 
[2–5]. While the first two factors do not affect dental 
implants and the rates of mechanical complications of 
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the implant itself are low, peri-implant infections are 
a major risk factor for implant failure [6]. Looking at 
the point in time when implants are lost, early and late 
explantation can be distinguished.
Early implant loss takes place before prosthetic load-
ing [7]. In those cases, osseointegration is not success-
ful, the implant is surrounded by connective tissue 
and can therefore not be used to anchor the planned 
denture. Some authors state, that the reasons for this 
event may be bacterial infections, surgical mistakes 
like inadequate cooling during implant bed prepara-
tion or an overload of the implant by a provisional den-
ture [7]. The only treatment option is to remove the 
implant and to repeat the surgical procedure, which is 
quite frustrating for both the patient and the surgeon. 
On the other hand, primary osseointegrated implants 
can lose their connection to the surrounding bone [6]. 
As a reason, bacterial infections of the peri-implant 
tissues have been reported in several investigations, 
similar to the pathogenesis of periodontitis [8]. The 
infection leads to an inflammatory response, caus-
ing peri-implant mucositis. If this soft tissue reaction 
is not controlled, the infection will lead to an inflam-
matory process of the peri-implant bone, resulting in 
bone resorption. This plaque-associated bone loss is 
defined as peri-implantitis [9]. Several health condi-
tions, such as periodontitis or diabetes and smoking, 
have been discussed as risk factors for peri-implantitis 
[8, 10, 11].
In the past decades, the knowledge of bacterial infec-
tions, especially biofilms, has changed fundamentally 
[12, 13]. While the thesis that pathogens in periodonti-
tis and peri-implantitis are similar had been suggested 
in several previous studies based on genetic analysis 
methods [14–16] it is meanwhile well established that 
there are certain differences regarding the microbiota 
in those diseases using new and more accurate diagnos-
tic methods [17–22]. Also the individual reaction of the 
immune system and changes of the bacterial constella-
tion around titanium implants have been discussed [23, 
24]. On the other hand, some authors even state, that 
qualitative findings in pockets of infected implants are 
similar to those in healthy sites, questioning if the num-
ber of bacteria is the main reason leading to the disease 
[25]. New findings could either support or question the 
knowledge of bacterial findings around dental implants. 
Furthermore, there is no data regarding bacterial pro-
files of early lost implants, emphasizing the need of this 
study.
The aim of this study was to analyze the bacterial 
population in the peri-implant pocket of implants with 
severe peri-implantitis and to compare the bacterial 
biofilm of implants of early and late loss.
Methods
The present clinical study investigated 53 dental implants 
from 48 patients. Main focus of the study was a microbial 
comparison of findings on the surface of implants which 
got lost during the time of osseointegration (early loss) 
and implant loss because of peri-implantitis (late loss). 
All results were collated by the same dentist at the Den-
tal Academy for Continuing Professional Development 
(Karlsruhe, Germany).
General inclusion criteria were: implants with bleed-
ing on probing (BOP) in combination with severe loss of 
the bone-to-implant contact, either in the period of heal-
ing after the insertion (< 3  months, “early loss”) or after 
uneventful osseointegration and loading (> 3 years, “late 
loss”). Exclusion criteria were: patients aged younger than 
18  years, radiation or bisphosphonate therapy, patients 
with untreated periodontitis and severe general condi-
tions, such as uncontrolled diabetes  (HbA1c > 58  mmol/
mol / > 7,5%), tumors, severe heart disease or a reduced 
state of general health. Patients who had taken antibiot-
ics within the last two months prior to sample collec-
tion were excluded. Smokers were not excluded from 
the study. Included were only patients with one or more 
implants which had been inserted in our clinic. Only 
implants with severe peri-implant bone loss and no 
chance of regeneration or preservation were included. 
Implants that cannot be preserved, due to severe peri-
implantitis, were defined as having increased peri-
implant pocket depth in combination with bleeding on 
probing, persistent symptoms and radiological bone loss 
of at least 6 mm. Also specimens from implants without 
peri-implantitis (no bone loss), BOP and pocket suppura-
tion were integrated into the study as a control group.
Implants with peri-implantitis and bone loss, but 
chances of preservation were excluded.
Study population.
Patients were divided into four groups:
27 patients with severe peri-implantitis and implants 
without a chance of preservation were divided in two 
groups.
• Group E: early implant loss (implants with severe 
peri-implantitis during osseointegration prior to 
prosthetic restoration, ≤ 3  months after implant 
placement), 13 patients with 14 implants
• Group L: late implant loss (implants with severe 
peri-implantitis and prosthetic restoration for more 
than three years), 14 patients with 17 implants (three 
patients with two implants)
 For a comparison to the healthy oral situation we cre-
ated two control groups:
• Group CE: control group (implants with no bone 
loss, no BOP and no pocket suppuration directly after 
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completed osseointegration, two to four months after 
implant placement), 17 patients with 17 implants
• Group CL: control group (implants with no bone 
loss, no BOP and no pocket suppuration and pros-
thetic restoration for more than three years), 5 
patients with 5 implants
Note that one patient contributed two implants to the 
late loss group (L) and an additional implant to group 
CE, effectively being counted twice in the number of 
patients per group. Three additional patients were ini-
tially recruited but not included in the analysis because 
they not fully met the inclusion criteria.
The implants were placed by three different surgeons 
with several years of experience.
The observational study was approved by the ethical 
review committee of the local medical association (Insti-
tutional Review Board of the Saarland Medical Council, 
Germany; ID: 232/12) and was conducted in accordance 
with the Declaration of Helsinki and the Professional 
Code for Physicians of the local Medical Council. All 
patients were informed about the purpose of the study by 
the examiner and signed a form of consent.
Clinical procedure of documentation of clinical find-
ings and sampling.
• Patients were asked about their case history, nicotine 
abuse, diabetes, regular use of mouth rinses (at least 
once per week) and antibiotics in the past 12 months, 
and if periodontitis had been diagnosed.
• In each patient a pool sample was taken with three 
sterile paper points from the peri-implant sulcus 
around infected or healthy implants. (Fig.  1). The 
supramucosal plaque was removed with a cotton 
swab prior to submucosal sample collection. The sur-
face of the denture was then air-dryed using the mul-
tifunctional syringe. Only after these measures were 
taken was the submucosal sample taken with a paper 
point. These measures prevented supra- and submu-
cosal plaque from being mixed during sample collec-
tion.
• Any existing signs of inflammation (pocket suppu-
ration) were documented. In patients with multiple 
implants, samples were collected for each implant 
separately, but the data were later pooled to prevent 
an unbalanced dataset.
• If a severe peri-implantitis was diagnosed, explanta-
tion was done under local anaesthesia with articaine 
with epinephrine 1:100.000 (Citocartin Sopira®, Her-
aeus Kulzer GmbH, Hanau, Germany).
All patients were informed in advance about the clini-
cal procedure to be performed. In addition, the patients 
were informed about obtaining paper point samples for 
a future microbial analysis in connection with the study. 
All patients gave their informed consent in writing.
For the microbial analysis of the peri-implant samples 
the bacterial DNA from the paper point of a total of 53 
implants from 48 patients were obtained and analyzed 
for taxonomic composition by sequencing the V1-V2 
variable regions of the 16S rRNA gene. The sequencing 
was performed in the Max Rubner-Institut, Karlsruhe, 
Germany.
The paper points were applicated for 20 s, following the 
established clinical routine for sample collection of peri-
implant pathogens [26].
Evaluation at patient level
Samples were obtained from each implant with three 
sterile paper points and then pooled. The data acquisition 
and microbiological evaluation took place at the implant 
level. For some patients multiple implants were analysed. 
In these cases, the microbial data were later pooled for 
the statistical analysis, effectively creating an average 
microbial composition of the implants obtained from the 
same patient.
One patient had samples from two groups (L and CE). 
In this case, the samples from the different groups were 
not pooled. The evaluation was therefore carried out at 
patient level.
Extraction of microbial DNA
Sterile paper points were used to collect biofilm sam-
ples of the peri-implant sulcus for microbiota analy-
sis as described previously [26]. The implants were also 
collected after explantation and their microbiota was 
likewise analyzed for control purposes. Briefly, biofilm 
Fig. 1 The figure shows a sample which was taken with sterile 
paper points from the peri‑implant sulcus around infected or healthy 
implants
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microbes were resuspended in nuclease free water by 
subjecting paper points (or implants) to a combination 
of shaking and sonication. The suspension was centri-
fuged, pellets were stored at − 80  °C and then used for 
DNA extraction using commercial extraction protocols 
for genomic DNA (QIAamp Mini Kit, Qiagen, Hilden, 
Germany). The collected pellets of the supernatant 
were treated with 180 µL lysozyme solution (20 mg/mL, 
SIGMA-Aldrich, Taufkirchen, Germany; 20  mM Tris–
HCl, pH 8.0, 2  mM EDTA, 1.2% Triton) under shaking 
at 37 °C for 2:15 h, followed by proteinase K digestion (20 
µL proteinase K and 200 µL buffer AL) for 1:15 h under 
shaking at 56  °C. Finally, the DNA was eluted with 100 
µL PCR-clean water and the concentration was quanti-
fied using the NanoDrop equipment (PEQLAB, Erlangen, 
Germany). One empty extraction without any sample 
material was used a control for background DNA con-
taminations (contamination control).
Illumina sequencing of amplicons targeting the 16S rRNA 
gene
Amplicons of the V1-V2 region of the bacterial 16S rRNA 
gene were prepared as published elsewhere [27]. Briefly, 
the genomic sequence of the 16S rRNA gene was ampli-
fied with primers that were derived from the previously 
described primers 27F and 338R [28, 29] and contained 
sequences compatible with Illumina sequencing plat-
forms and a 6-nt barcode sequence. The resulting DNA 
was used as template for a second PCR, using prim-
ers designed to introduce full-length Illumina adapter 
sequences including Illumina 6-nt index sequences to 
enable high-level multiplexing. To control for potential 
DNA contamination an additional sample was amplified 
without template DNA (contamination control sample). 
Libraries were pooled and subjected to 250 nt paired-
end sequencing on an Illumina MiSeq machine. For data 
analysis, the obtained raw reads were first demultiplexed 
based on barcode sequences and primer sequences 
removed using a Perl script, thereby removing reads 
that did not contain the primer sequence. Further, the 
reads were processed using dada2 version 1.16.0 [30]. 
Dada2 determines amplified sequence variants (ASVs) 
by removing sequencing errors, effectively denoising 
the data, which tends to produce more accurate results 
than the commonly used operational taxonomic units 
or OTUs [31]. Briefly, sequence reads were trimmed to 
a length of 200 nt (forward read) and 150 nt (reverse 
read) and 5 nt of the left end were trimmed additionally. 
Reads with ambiguous base calls and an expected error 
rate larger than 2 were discarded and ASVs were inferred 
using the pseudo-pooling algorithm. Chimeric sequences 
were removed and ASVs classified using the RDP Naïve 
Bayesian Classifier algorithm as implemented in dada2 
against the Silva database v138 [32]. Were possible by 
exact matching, ASVs were assigned species names using 
the assignSpecies function of dada2. After the preproc-
essing the data amounted to between 1305 and 205,073 
sequences per sample.
Statistical analysis of microbiome data
Further analysis of the microbiome data was done in R 
version 3.6.1 [33] using packages phyloseq [34], vegan 
[35] and ggplot2 [36]. The contamination control sample 
yielded 397 reads and 13 ASVs represented by more than 
5 sequences in the contamination control were removed 
from all samples. Alpha-diversity of the sampled biofilms 
was estimated using the Inverse Simpson Index, calcu-
lated by the phyloseq function estimate_richness. Princi-
pal coordinates analyses (PCoA) were performed using 
the ordinate function with Jenson-Shannon Divergence 
(JSD) as distance metric. Differences of single variables 
between groups of samples were statistically tested using 
the Kruskal–Wallis Rank Sum Test (R function kruskal.
test) for multiple groups and Wilcoxon Rank Sum Test (R 
function pairwise.wilcox.test) for pairwise comparisons 
of groups with the Benjamini–Hochberg adjustment to 
control false discovery rate in multiple comparisons [37]. 
Differences in the microbiota composition (beta-diver-
sity) were tested by performing Permutational Multi-
variate Analysis of Variance (PERMANOVA) on the JSD 
matrix, using the adonis function of the R package vegan 
[35] and pairwiseAdonis by Martinez Arbizu & Mon-
teux [38]. Differential abundances of species were calcu-
lated by merging ASVs that were classified to belong to 
the same species (or genus for those ASVs that could not 
be classified at the species level) and by comparing two 
groups with the R package ALDEx2 v1.20.0 [39] using 
the functions aldex.ttest and aldex.effect. Species were 
defined as differentially abundant, if the p-value of the 
Welch test was less than 0.05.
The study was conducted in accordance with the 
STROBE guidelines (https ://www.strob e-state ment.org).
Results
Composition of the peri‑implant microbiota
Across all samples, 552 taxa (amplified sequence vari-
ants, ASVs) were detected that occurred with an abun-
dance of at least 1% in one or more samples. Most of the 
identified taxa belonged to the six phyla Actinobacteriota, 
Bacteroidota, Firmicutes, Fusobacteriota, Proteobacteria 
and Spirochaetota. All samples could be analyzed and 
were included in the study.
The microbial composition of the peri-implant bio-
film samples showed substantial variation between 
individual patients, most ASVs were not found in all 
patients, even when comparing only patients of the 
Page 5 of 11Korsch et al. BMC Oral Health          (2021) 21:112  
same group (Fig.  2). Representatives of bacterial gen-
era that were found in most samples (though at variable 
abundance) included Streptococcus and Fusobacterium. 
Most of the Streptococcus ASVs could not be classi-
fied at the species level with a few exceptions like S. 
sanguinis and S. canis. Some taxa were found rarely 
or not at all in most samples but were found at high 
abundances in single samples. This included extreme 
cases, were ASVs of a single genus (Rothia, Aggregati-
bacter and Gemella) comprised more than 50% of the 
sequences. Despite the large variability, a comparison 
of the composition across all samples revealed a pattern 
that partially matched the different groups of patients 
(Figs. 2, 3). Most notably, most of the patients who lost 
their implants (groups E and L) could be distinguished 
from their respective control groups (Fig. 3b, c). While 
the samples of group L clustered together on the right 
side of the plot (with two exceptions), the samples of 
group E showed larger differences. Some of the latter 
clustered with the L samples, some with the control 
samples. The difference in the composition of the dif-
ferent groups was found to be statistically significant, 
either when all groups were compared with each other 
or only the implant loss groups with their respective 
controls (p <  10–5, PERMANOVA Test on the beta-
diversity). Patients with implant loss showed increased 
average abundances of Fusobacterium and Porphy-
romonas (Fig.  2b) and the most abundant species of 
these genera, F. nucleatum and P. gingivalis contributed 
strongly to the placement of the respective samples in 
the PCoA plot (Fig. 3). The two healthy control groups 
on the other hand harbored comparatively high abun-
dances in bacteria of the genera Streptococcus, Neis-
seria, Rothia and Veillonella (Figs.  2b, 4). So far, the 
analysis compared the microbial compositions based 
on beta-diversity, thus on a global level. We also com-
pared the data on the level of species to give further 
insights into the differential abundance of certain bac-
teria under different conditions. Comparison of the late 
loss groups with each other and their respective control 
groups results in a limited list of differentially abundant 
species (Table 1). Five species were found to be signifi-
cantly higher in group L than in E, namely Desulfobul-
bus sp., Pseudoramibacter alactolyticus, Treponema sp., 
Fretibacterium sp. and a species of Anaerovoracaceae, 
but the effects were quite small. Comparing groups E 
and L with their controls, there were 3 and 10 species 
found to be differentially abundant, respectively. Some 
bacteria were found to be differentially abundant in 
two of these comparisons, Desulfobulbus sp., P. alac-
tolyticus and Fretibacterium, all of which were found 
to be higher in late loss group L compared to the con-
trol group CL. In addition, Streptococcus sanguinis was 
found to be reduced in E compared to the control CE, 
while Streptococcus sp. was reduced in L compared to 
CL.
A number of parameters were collected for each 
patient, some of which could impact on the microbial 
composition (Additional file 1). Firstly, these parameters 
were tested if they were evenly distributed among the 
groups. The parameters gender, implant region, diabe-
tes, antibiotic use (within 12 to 2 months prior to sam-
pling), and regular mouthwash showed no significant 
deviation from an even distribution (p > 0.05, Fisher’s 
exact test). The type of implant system used showed 
some bias however, with the majority of implants being 
of type “Astra”, which were overrepresented in groups E 
and CE (p = 0.040). Also, smoking was unevenly distrib-
uted (p = 0.048) with smokers being overrepresented in 
groups E and L (77 and 78%, respectively) as compared 
to CE and CL (35 & 40%). Another important factor is 
periodontitis, which was diagnosed if found anywhere in 
a patient and not only close to the implant that was ana-
lyzed. Patients with implant loss had a higher incidence 
of periodontitis (E: 64%, L: 71%) than the control groups 
(CE: 29%, CL: 20%). The impact of these potential con-
founders on the microbial data was tested by adding each 
one as an independent variable to the PERMANOVA 
Test on beta-diversity between groups. Antibiotic use 
and periodontitis both had no significant effect on beta-
diversity, while the differences between groups still were 
significant in the extended models. Likewise, the param-
eters diabetes, implant system smoking and regular 
mouthwash had no significant effect.
Biofilm samples were also analyzed directly from 
implants after the explantation and compared to the 
corresponding paper point samples to validate the 
results. The differences in the microbial composition 
were highly similar between implant and paper point 
samples. Although a multivariate analysis of the com-
position (PERMANOVA) did show a significant differ-
ence between implants and paper points  (R2 = 0.021, 
p = 0.016), it was small compared to the difference found 
between the groups  (R2 = 0.107, p <  10–4).
Discussion
In the last decades several risk factors for the failure 
of dental implants have been reported – most of them 
being clinical aspects of the implant treatment, medi-
cations or health conditions. Looking at the clinical 
risks for bone loss around implants, surgical skills or 
mistakes regarding the surgical protocol, such as dull 
burrs, high pressure while drilling or high insertion 
torque, different healing protocols or excess of cement 
can cause problems [40–43]. On the other hand, medi-
cations, such as bisphosphonates or antidepressants 
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can be risk factors for infections or implant loss [44–
46]. Additionally, certain conditions, such as poor bone 
quality, periodontitis, bruxism, overload or mechanical 
complications and smoking habits can have an impact 
on osseointegration and long-term success of dental 
implants, while controlled diabetes, osteoporosis or 
the age of the patient do not seem to be risk factors 
[47–54].
Among those reasons for implant failure, bacterial 
infections have been reported to be a major risk factor 
for early and late loss of dental implants [7, 52, 55, 56]. 
Most of the studies focus on the microbial findings in 
peri-implantitis, while there is no data for early loss. Dif-
ferences between research groups could be explained by 
different test systems and by the steady development of 
microbial tests. The microbial findings in peri-implantitis 
resemble that of periodontitis, with some notable differ-
ences [17, 19, 20, 56]. Although certain known periodon-
tal pathogens may also be associated with the etiology of 
peri-implantitis, apparently there were many differences 
between these two clinical conditions, involving distinct 
microorganisms [20].
The results obtained in this study present a very het-
erogeneous picture of the microbes found around failed 
dental implants. A huge majority of this variation can 
likely be attributed to differences between patients that 
have no association with any clinically relevant param-
eters. Overall, the statistical analysis proved difficult due 
the huge underlying variation and the limited sample size 
of the study groups, resulting in only few bacterial groups 
showing differential abundances between groups that 
were statistically significant. Nevertheless, both early and 
late loss samples showed some similarity and on aver-
age could be distinguished from their respective control 
groups (Fig. 3). Thereby, the group of late loss samples (L) 
formed a more compact group with the exception of two 
samples, while early loss samples appeared to be more 
heterogeneous.
Our findings show that in the group of late lost 
implants pathogens such as Tannerella forsythia and 
Table 1  Differential abundance of Species between different groups
abund X: relative abundance of species in group X (clr transformed)
FDR: False discovera rate (Benjamini Hochberg corrected P value, Welch-test)
effect: ratio of median between-group differences and within-group differences
uncl.: indicates that this taxon was not classified on a lower rank
Species name FDR Abund L Abund E Effect
Pseudomonas sp 0.0070 1.86 6.50 − 1.18
Anaerovoracaceae uncl 0.0240 8.82 4.07 0.94
Desulfobulbus sp 0.0142 8.82 − 0.44 1.15
Pseudoramibacter alactolyticus 0.0079 7.23 − 0.37 1.21
Treponema sp 0.0151 10.48 1.62 1.04
Pantoea sp 0.0064 2.69 7.89 − 1.13
Fretibacterium sp 0.0170 9.21 2.00 1.02
Shewanella sp 0.0078 2.75 7.55 − 1.09
Species name FDR Abund L Abund CL Effect
Rothia sp 0.0187 2.41 10.56 − 1.06
Streptococcus sp 0.0063 9.20 12.48 − 1.52
Desulfobulbus sp 0.0209 8.79 − 1.74 1.73
Pseudoramibacter alactolyticus 0.0256 7.18 − 1.40 2.10
Fretibacterium sp 0.0555 9.18 − 0.55 1.55
Haemophilus parainfluenzae 0.0015 2.36 8.62 − 1.65
Haemophilus sp 0.0035 2.63 9.32 − 1.52
Dialister pneumosintes 0.0333 4.93 − 1.98 1.43
Capnocytophaga sp 0.0930 2.14 7.00 − 0.94
Granulicatella sp 0.0299 − 0.09 5.87 − 1.12
Species name FDR Abund E Abund CE Effect
Streptococcus sanguinis 0.0061 3.69 9.99 − 1.40
Lautropia mirabilis 0.0539 1.60 7.90 − 1.00
Actinomyces naeslundii 0.0961 0.43 6.26 − 0.84
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Treponema sp., were frequently found around implants, 
which had to be removed because of severe bone loss 
after a primarily uneventful osseointegration. Addition-
ally, Porphyromonas gingivalis and Fusobacterium nucle-
atum were found in early and late loss, although the latter 
was found in several variants all classified as the same 
species, only some of which contributed to the com-
munities in the late loss samples. The statistical analysis 
also revealed increased abundances of Desulfobulbus sp., 
Fretibacterium sp. and Pseudoramibacter alactolyticus 
which were also previously found in peri-implant sites 
[57, 58].
For early loss of implants, the microbial results were 
very heterogeneous and only a subset of these cases 
were similar to the major part of late loss samples, while 
a large fraction resembled the healthy controls. Some 
of the samples in this group were each dominated by a 
single genus, notably Fusobacterium, Aggregatibacter 
and Gemella that accounted for more than 50% of the 
microbial sequences found in these samples (Fig.  4). 
Such samples might partially explain the observation that 
implant lost early had a lower microbial diversity (Fig. 2a) 
than the late loss implants. This heterogeneity between 
patients points towards multiple potential risk factors 
contributing to early implant losses, which might include 
i) characteristic microbial communities, ii) dysbiosis 
involving other oral bacteria and iii) other, non-microbial 
causes like surgical mistakes or poor bone quality. Stud-
ies on the early bacterial colonization of healthy implants 
show a biofilm similar to that of remaining teeth [59–61]. 
Especially Streptococcus as an early colonizer is com-
monly found in high abundance [59–61], which is also 
reflected in our own data. A comparison in the early 
healing phase of implants of patients with chronic peri-
odontitis and volunteers without periodontitis showed 
that the presence of bacterial species associated with per-
iodontitis was always higher in the chronic periodontitis 
group; the difference was significant for Porphyromonas 
gingivalis and Aggregatibacter actinomycetemcomitans 
[62]. It should be noted that these bacteria are commonly 
found in the context of healthy implants in low numbers 
and their mere presence is not indicative of periodontitis 
[61, 63, 64].
The use of antibiotics is included in many implanto-
logical protocols. This approach has an impact on the 






























































Fig. 2 a Alpha‑diversity of microbial composition in samples of implant groups. The groups of implants are labelled CE—early control, E—
early implant loss, CL—late control, L—late implant loss. Diversity was calculated using the inverse Simpson index and is here depicted as 
box‑and‑whiskers‑plots with the box representing values between the 1st and 3rd quartile, a black line indicating the median. b) Average relative 
abundance of the most abundant genera across implant groups. All sequence variants (ASVs) that were classified to belong to the same genus 
were aggregated. Horizontal lines indicate a significant difference in the microbiota composition between groups (pairwise Wilcoxon and pairwise 
PERMANOVA analysis in a, b, respectively). Asterisks in both panels indicate significance levels: *p < 0.05, **p < 0.01)
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antibiotics within the last two months prior to explanta-
tion were excluded. However, about half of the patients 
used antibiotics within 12 to 2  months prior to sam-
pling. We therefore tested the effect of antibiotics on the 
microbial composition but found no differences between 
patients with and without the use of antibiotics.
In the present study, regular use of mouthwash did not 
show any significant impact on the peri-implant microbi-
ome. It is known that mouthwash affects the supragingi-
val biofilm [66–68]. However, it is unclear which kind of 
affect a mouthwash with common rinsing solutions has 
on the submucosal biofilm of implants. The heterogene-
ity within the groups and the small number of cases may 
have had an influence on the present results. There was 
a number of additional potential confounding variables 
that might have affected the microbial composition in 
the patients examined: use of diabetes, smoking, differ-
ences in the implant system and especially periodontitis. 
The distribution of smokers and implant systems was 
indeed biased between the different groups. Smokers 
were overrepresented in both groups with implant loss 
and less present in the control groups but the micro-
bial composition showed no significant difference. This 
might hint towards an effect of smoking on the out-
come, which is independent from the microbial coloni-
zation. The implant systems were biased with the System 
Astra being overrepresented in the “younger” implants 
of groups E and CE, which might be due to the fact that 
these implants were placed by the same surgent. Astra 
was the main implant system in this clinic at the time. 
Most other implant systems were represented only in few 
numbers, so we cannot draw conclusions on this factor 
and besides, the microbial composition was not different 
between the different systems. A potentially important 
factor for the occurrence of inflammation and source 
of oral pathogens is the diagnosis of periodontitis. The 
observation that patients with implant loss were more 
likely to also be diagnosed with periodontitis than those 
of the control groups indeed hints that it could be an 
important contributing factor. Notably, we nevertheless 
found no significant difference in the composition of the 
implant-associated biofilm in patients with periodontitis, 
although some periodontal pathogens were found to be 
abundant in patients with implant loss. In a mixed model 
with periodontitis and the experimental group as inde-
pendent factors, the microbial composition was found to 
be different between the groups but not between patients 
with and without periodontitis. Thus, although periodon-
titis seems to be a potential factor for implant failure, the 
composition of the implant-associated biofilm appears to 
be independently associated.
Because of the sample size, the data presented should 
be interpreted as a first indication, especially regarding 
to the heterogeneous findings in early implant loss. It 
can also not be distinguished, if the bacterial coloni-
zation is the reason for the loss of the implant, or if it 
represents a secondary infection after osseointegra-
tion failed or was lost. This underlines the importance 
of further studies that include a higher number of 
implants that also assess the different potential risks of 
early losses.
Conclusions
Summarizing, samples from late lost implants formed 
a more homogeneous group in terms of their micro-
bial composition, while early loss samples appeared to 
be more heterogeneous. In general, early lost implants 
showed also lower microbial diversity than late losses. 
However, the microbial results were not indicative of the 



















































































































































Fig. 3 Principal coordinates analysis (PCoA) of relative abundances 
of ASVs across all samples. Individual samples are depicted as circles, 
colored by group of implants as labelled: CE—early control, E—early 
implant loss, CL—late control, L—late implant loss. a Biplot showing 
also arrows that represent the “loadings”, i.e. the contribution of the 
20 most abundant sequence variants (ASVs) and are labelled with the 
species classification (if available). Axis.1 and Axis.2 represent the first 
two principal coordinates with the fraction of total variance explained 
by each coordinate written in square brackets. b, c PCoA plots of 
the early (E) and late (L) loss group of implants with their respective 
control groups
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